Disease Area

beta thalassemia

Beta Thalassemia is an active area of clinical research and therapeutic development covered by The Life Science Feed. Our editorial team tracks the latest clinical trials, treatment guidelines, regulatory updates, and scientific advances relevant to Beta Thalassemia. Browse the latest articles below for in-depth analysis and evidence-based clinical insights.

Beta-Thalassemia
Gene therapy for thalassemia: Approval is one hurdle, access is the next
Gene therapy offers a new treatment option for thalassemia, but the complex logistics and high costs present significant barriers to patient access.
Get the full story
10 min read
Beta-Thalassemia
Iron chelation in gene therapy: When to stop, and how to monitor
Gene therapies for transfusion-dependent anemias introduce new questions about iron overload management. Clinicians must determine optimal chelation cessation and monitoring strategies.
Get the full story
10 min read
Beta-Thalassemia
CRISPR-edited cells offer durable transfusion independence in beta-thalassemia
Exagamglogene autotemcel, a CRISPR-based gene-editing therapy, provides sustained transfusion independence for patients with transfusion-dependent beta-thalassemia.
Get the full story
10 min read

Loading articles...